Where can you check an answer?

Liraglutide (Saxenda): official medicine information

This information explains who the weight-use product is for, possible harms, pregnancy concerns, and checks for prescribers.

Liraglutide (Victoza): official medicine information

The information for the diabetes-use product differs from the information for the weight-use product.

The SCALE adult weight study

The SCALE weight study followed adults without diabetes for 56 weeks.

Among those given liraglutide, the average weight lost was 8.4 kilograms, or about 18.5 pounds.

The group given a dummy shot with no active drug lost an average of 2.8 kilograms (about 6.2 pounds).

These are group averages, not a prediction of one person’s result.

Severe allergy: when help is urgent

MedlinePlus describes severe allergy as an emergency and explains when to seek urgent help.

Find the relevant medical board

The Federation of State Medical Boards directory points to the state boards that keep doctors’ license records.

Use the board’s own record to check a doctor’s name and license.

Check the pharmacy’s state record

FDA means the U.S. Food and Drug Administration.

FDA’s checking page leads to state pharmacy records; it says to avoid an online pharmacy that is absent from the state list.

What the boards say about online assessment

The May 2026 medical-board guidance rejects treatment chosen from a menu alone and calls for a chance to ask follow-up questions.

The group gives advice to state boards; requirements are set by the rules in each state.

State permission for remote care

As of September 2026, HHS, the U.S. health department, describes another way some states permit online care.

Those states may let a doctor who holds a license elsewhere use registration for online care in place of a full license in the patient’s state.

Ask the service which state record you can use to check that permission.

What compounding means

Compounded describes medicine that is prepared to order.

Medicines prepared to order lack FDA approval as of September 2026, and reach sale without the agency first reviewing their quality, benefits, or harms.

Supply and the national shortage listing

The September 2026 record still lists liraglutide injection in shortage.

Proposed rule for places that make medicine in batches

Larger facilities prepare batches of medicine, frequently supplying hospitals and clinics.

FDA has proposed leaving liraglutide off the list of raw ingredients these facilities may use to make medicine.

It had not made a final decision as of September 2026.

If a made-to-order product is offered, ask where it would be made and which rule allows it.

Online offer checks

FDA’s checklist flags skipped prescriptions, misleading approval claims, and missing access to a doctor for later questions.

Medicare’s separate weight-loss payment program

The GLP-1 Bridge is Medicare’s separate way to pay for certain medicines for weight loss, and it operates temporarily.

Medicare’s temporary program for weight-loss medicines does not include liraglutide as of September 2026.